Abstract
Abstract:After a subarachnoid hemorrhage, a 35-year-old patient developed paroxystic hypertension accompanied by typical symptoms. These symptoms occurred exclusively after urination. A urinary bladder paraganglioma was discovered using iodine-123 metaiodobenzylguanidine (I-123 MIBG) scintigraphy and magnetic resonance imaging (MRI) after the detection of an abnormally elevated plasma metanephrine measurement. A partial cystectomy was performed which cured the symptoms. Paragangliomas, defined by their extra-adrenal localization, have slightly different characteristics than pheochromocytomas, leading to specific care and follow up.
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
References
References1. Plouin PF, Gimenez-Roqueplo AP. Pheochromocytomas and secreting paragangliomas. Orphanet J Rare Dis 2006;1:49–55.PlouinPF]]Gimenez-RoqueploAPPheochromocytomas and secreting paragangliomas.Orphanet J Rare Dis2006149-552. Baguet JP, Hammer L, Mazzuco TL, et al. Circumstances of discovery of pheochromocytoma: a retrospective study of 41 consecutive patients. Eur J Endocrinol 2004;150:681–686.BaguetJP]]HammerL]]MazzucoTL&etal;Circumstances of discovery of pheochromocytoma: a retrospective study of 41 consecutive patients.Eur J Endocrinol2004150681-6863. Kwekkeboom DJ, van Urk H, Pauw BK, et al. Octreotide scintigraphy for the detection of paragangliomas. J Nucl Med 1993;34:873–878.KwekkeboomDJ]]van UrkH]]PauwBK&etal;Octreotide scintigraphy for the detection of paragangliomas.J Nucl Med199334873-8784. Baguet JP, Hammer L, Tremel F, et al. Metastatic pheochromocytoma: risks of diagnostic needle puncture and treatment by arterial embolisation. J Hum Hypertens 2001;15:209–211.BaguetJP]]HammerL]]TremelF&etal;Metastatic pheochromocytoma: risks of diagnostic needle puncture and treatment by arterial embolisation.J Hum Hypertens200115209-2115. Gimenez-Roqueplo AP, Lehnert H, Mannelli M, et al; European Network for the Study of Adrenal Tumours (ENS@T) Pheochromocytoma Working Group. Pheochromocytoma, new genes and screening strategies. Clin Endocrinol (Oxf) 2006;65:699–705.Gimenez-RoqueploAP]]LehnertH]]MannelliM&etal;European Network for the Study of Adrenal Tumours (ENS@T) Pheochromocytoma Working GroupPheochromocytoma, new genes and screening strategies.Clin Endocrinol (Oxf)200665699-7056. Amar L, Bertherat J, Baudin E, et al. Genetic testing in phaechromocytoma or functional paraganglioma. J Clin Oncol 2005;23:8812–8818.AmarL]]BertheratJ]]BaudinE&etal;Genetic testing in phaechromocytoma or functional paraganglioma.J Clin Oncol2005238812-88187. Amar L, Servais A, Gimenez-Roqueplo AP, et al. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab 2005;90:2110–2116.AmarL]]ServaisA]]Gimenez-RoqueploAP&etal;Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma.J Clin Endocrinol Metab2005902110-2116
